Despite substantial improvements in recent decades, the prognosis for those cancer patients who suffer from metastatic disease and depend on systemic drug therapy remains poor. Both intrinsic resistance and the formation of acquired drug resistance substantially affects the efficacy of cancer drugs. The advancement of precision medicine approaches holds promise for both the effective guidance of therapies to patients that will respond and the ability to monitor this tumour response. This will require the successful interpretation of ‘omics’ data and a close collaboration between pre-clinical researchers, clinicians, and computational biologists in both academia and industry to develop these strategies. This conference will bring together and showcase cancer researchers from these areas, who will present and discuss the latest advances in understanding the mechanisms of drug resistance in cancer, the identification of biomarkers of drug sensitivity/resistance and how they can be linked to precision medicine approaches.

 

Topics to include:

• Molecular mechanisms of resistance
• Genomics, systems biology and tumour evolution
• Models of tumour resistance
• Immuno-oncology and therapy

Location: University of Kent, Canterbury

Find out more

 

At this year’s PING Conference, attendees will have the chance to learn from industry experts who will delve into the practical implications of AI in pharma. Covering insightful case studies, delegates will hear about both risks and opportunities leaving them better placed to face and prepare for what is coming.

There will be plenty of opportunities to network with other industry players. Following the afternoon sessions, enjoy outside drinks in the venue’s picturesque grounds, and then a relaxed evening with entertainment that promises to bring some magic to the day, and dinner.

Don’t miss your chance to engage with innovators and leaders in the pharmaceutical industry as they explore the theme of this year’s conference, AI in Pharma – Threat or Opportunity?

Register here

Join us as we attend GIANT Health 2024 at the Business Design Centre in London!

GIANT Health is the leading, rapidly expanding UK community (of over 345,000 people) of NHS leaders, clinicians, and everyone who’s business is health, tech, and innovation.

The GIANT (Global Innovation and New Technology) Health Event is the UK’s leading, unmissable NHS innovation festival; with 6+ “shows within the festival”. Come meet, network, learn, and do business with 100s of world-class speakers, experience immersive innovation presentations, see the UK’s leading health-tech start-ups pitching to investors show, and more.

Discovery Park is excited to partner with Giant to present the Innovation, Investment, and Impact Show – a specially curated show within the wider event, designed to provide valuable insights and opportunities for early-stage entrepreneurs and founders in the healthcare and life sciences sectors. This event is equally interesting to investors looking to connect with high-potential ventures while gaining a deeper understanding of the evolving industry landscape.

Find out more and register here

Join us as we attend the 2024 SEHTA International MedTech Expo & Conference near Tower Bridge in London!

For the last 19 years, Science & Engineering Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1,500+ members. Especially SMEs, through its business support, commercialisation, mentoring and events programmes.

The SEHTA conference and expo helps delegates:

• Showcase: A range of highly innovative and adoptable technologies
• Navigate: Make sense of the complexities of health and social care delivery, and the challenges of accessing the NHS.
• Find: Funding opportunities with Investors & Accelerators from both private and public sources
• Identify: Current clinical challenges in the NHS

Find out more and register here

Join us as we attend LSX World Congress at the Business Design Centre in London!

The 10th LSX World Congress is the leading partnering, strategy and investment event in Europe. The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

Find out more and register here

Join Discovery Park as we attend the LSX World Conference! We look forward to exhibiting at the event.

The conference will bring together CEOs and senior decision-makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, and R&D leaders.

Find out more

 

This event will discuss the major challenges impacting the HealthTech sector in this one-day gathering of technology, diagnostics, devices and therapeutics organisations, clinicians and regulators.

Our Chief Business Officer, Jane Kennedy, will be taking part in a Fireside Chat with Martin Carpenter, Chief Digital Transformation Officer, NHS Kent & Medway.

Find out more